Stocktoria
FEMASYS INC FEMY
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-06-18
FEMASYS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | — | — | — | 63.4% | 68.6% |
| Operating margin | -767.0% | -1091.8% | -1353.4% | -961.7% | -706.7% |
| Net margin | -812.3% | -1155.0% | -1329.1% | -944.6% | -639.0% |
| FCF margin | -837.9% | -1240.3% | -1065.7% | -923.5% | -698.3% |
| Return on assets | -89.9% | -151.2% | -51.3% | -67.4% | -26.4% |
| Return on equity | -317.4% | -816.5% | -77.6% | -74.8% | -28.6% |
| Current ratio | 4.53 | 0.93 | 7.59 | 9.25 | 15.15 |
| Revenue growth | 40.8% | 52.0% | -11.1% | 2.2% | 13.7% |
Source: SEC EDGAR filings · CIK 0001339005 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.